Date: 30 April 2025
Time: 09:30 – 15:45
Location: Institut Curie
Paris Symposium
"T-cells and Antigen-Specificity – Applications in Infectious Disease and Immuno-Oncology"
In April, Immudex will be hosting a symposium in Paris where scientists will give presentations about their research in the area of T cells and antigen specifity.
REGISTRATION IS CLOSED.
Program
| 09:30 - 10:00 | Welcome coffee |
|
10:00 - 10:30 |
“Reawakening T cell responses in chronic HBV” Dr. Pierre Tonnerre Group Leader ATIP-Avenir, Institut de Recherche Saint-Louis |
| 10:30 - 11:00 |
“Synthetic antigen presenting cell engagers – Simplify activation and expansion of specific T cells” Dr. Liselotte Brix Chief Scientific Officer, Immudex |
| 11:00 - 11:30 |
“Harnessing gut immunity to target metastases” Dr. Christel Devaud Researcher, CRTC, Centre de Recherche du Cancérologie |
| 11:30 - 12:00 |
“Polyepitopic T cell responses following T-cell receptor treatment of uveal melanoma patients” Dr. Ana Lalanne Staff Scientist, Institut Curie |
| 12:00 - 13:00 | Lunch & Get together |
| 13:00 - 13:30 |
“BiXAb® MAIT Engagers: Engaging a Specific Cytotoxic T-Cell Subset to Control Solid Tumors” Dr. Julie Prigent Associated Director, BioMunex Pharmaceuticals |
| 13:30 - 14:00 |
“Resident memory TCD8 (TRM) in Cancer and Immunotherapy” Dr. Thi Tran Research Engineer, Inserm U970-PARCC- Université Paris Cité |
| 14:00 - 14:30 |
“Antigen-specific CD8+ T cells in autoimmune type 1 diabetes: raising the bar to detect ultra-low frequencies” Prof. Dr. Roberto Mallone Permanent Researcher, Institut Cochin |
| 14:30 - 15:00 |
“Regulation of anti-tumour immune responses by splicing of transposable elements” Dr. Marianne Burbage Inserm Researcher (CRCN), Institut Curie |
| 15:00 - 15:45 | Closing remarks & Networking |
Meet the Team
Michela Venturi, PhD
Sales Development Manager
Liselotte Brix, PhD
Chief Scientific Officer
Henrik M. Pfundheller
Chief Commercial Officer